An $11 million multi-institutional grant from the NIH BRAIN Initiative will enable Berndt Lab engineer new red calcium and neuromodulator sensors, giving scientists much more powerful tools to study brain function and neurological disease. Read More
A global network of stem cell cores that includes ISCRM’s Tom and Sue Ellison Stem Cell Core has received a 2026 Public Service Award from the International Society for Stem Cell Research (ISSCR). Read More
ISCRM faculty member Kelly Stevens is the senior author of a study, published in Science Advances, that unveils 3D reconstructions of human liver tissue offering unprecedented detail at the cellular level. Read More
ISCRM researchers have shown that an AI-designed signaling protein (known as a ligand) can be used to mature ameloblasts capable of secreting more mineralized enamel, representing another important step forward for regenerative dentistry. Read More
The Freedman Lab used a single pool of stem cells to generate multiple cell types crucial for kidney function and showed it may be more effective to kickstart this process in vivo instead of engineering tissue outside the body for transplantation. Read More
In late January, nearly 60 researchers from ISCRM and the Molecular Engineering and Sciences Institute gathered to foster collaborations aimed at accelerating disease research through improved modeling technologies. Read More
The use of computational protein engineering technology to engineer transient, membrane-less organelles inside living cells is the subject of a new study led by the DeForest Research Group in collaboration with the Baker Lab. Read More
Dr. Min (Mia) Yang has received an NIH Director’s New Innovator Award that will enable her lab to shed light on the dynamics of chromosomal instability during a narrow, but formative window of time in the early human embryo. Read More
Exciting leadership news! Dr. Jennifer Davis has been named the new Director of the Institute for Stem Cell and Regenerative Medicine Read More
An interdisciplinary team of ISCRM researchers has received an $8.6 million grant from the NIH to accelerate cell therapies for diabetes by achieving more reliable and reproducible generation of fully functional pancreatic islets from multiple stem cell lines. Read More